Pharmafile Logo

News and Press Releases

Sanofi and Orano join forces to develop next-generation radioligand medicines

17 October 2024 -- Paris, France -- Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 17, 2024

Sanofi
One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in adults and adolescents...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 20, 2024

Regeneron
ukinfo@regeneron.com
The Charter Building, Vine Street, Uxbridge, Middlesex, United Kingdom, UB8 1JG

ERS: Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies

Pooled results from the BOREAS and NOTUS studies show meaningful clinical benefit with 31% reduction in exacerbations along with lung function improvement Data from these two phase 3 studies supported...

Category: Clinical Trials, Drug Delivery, Pharmaceutical
Posted: September 10, 2024

Sanofi
One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor

Manufacturing of instruments, consumables and reagents for cell and protein analysis Consolidation of existing sites and functions in Ann Arbor Overall investment of around $100m. 5 June 2024 -- Michigan,...

Category: BioManufacturing, Manufacturing and Packing, Pharmaceutical
Posted: June 5, 2024

Sartorius Group
info@sartorius.com
Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, predictive design of manufacturing processes and...

Category: Biotechnology, Drug Discovery
Posted: May 16, 2024

Sartorius Group
info@sartorius.com
Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany

Sartorius Collaborates with Sanofi to Commercialise End-To-End Platform for Downstream Process Intensification

Sartorius selected as preferred partner for development and commercialisation of integrated and continuous biomanufacturing (ICB) platform Modular platform will combine highest flexibility with standardisation ICB supports lower resource consumption and...

Category: BioManufacturing, Pharmaceutical
Posted: May 13, 2024

Sartorius Group
info@sartorius.com
Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany

Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Collaboration to advance TheWell Bioscience animal-free hydrogel solutions for 3D cell models Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery...

Category: Drug Discovery
Posted: April 9, 2024

Sartorius Group
info@sartorius.com
Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany

ArgusEye introduces AugaOne to accelerate downstream bioprocess development

AugaOne sensor system provides specific, real-time and automated data to reduce mAb process development time New sensor will be exhibited at the Bioprocessing Summit, 18-21 March 2024, booth 66. 21...

Category: Biotechnology
Posted: March 21, 2024

ArgusEye
info@arguseye.se
Fridtunagatan 24 582 13 Linköping Sweden

Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency

Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real-time data capture 6 February 2024 -- New York, US -- Medidata, a Dassault Systèmes company...

Category: Clinical Trials
Posted: February 7, 2024

Medidata
helpdesk@mdsol.com
350 Hudson Street New York, NY 10014 USA